Decoding Hypertension: The Surprising Truth About Primary Aldosteronism
Title: Unmasking the Hidden Epidemic: Primary Aldosteronism
In the realm of hypertension, primary aldosteronism (PA) emerges as a critical but often overlooked player. Frequently misdiagnosed, PA presents unique challenges and opportunities in patient care. But why should we care about it, and how can we navigate its complexities? #PrimaryAldosteronism #Hypertension
**Diagnosis and Screening**
Diagnosing PA is paramount yet straightforward, involving a blood test measuring aldosterone and renin levels. Shockingly, less than 1% of hypertensive patients are screened for PA, despite its presence in up to 15% of cases. Screening is essential for anyone with hypertension, particularly those with type 2 diabetes, unexplained atrial fibrillation, or resistant hypertension. #ScreeningMatters #BloodPressure
**Treatment Options**
For unilateral PA, adrenalectomy offers a surgical cure, significantly enhancing blood pressure control and quality of life. However, it carries surgical risks and may lead to glucocorticoid insufficiency post-operation. For bilateral PA, lifelong medical therapy with mineralocorticoid receptor antagonists helps manage symptoms and reduce health risks. #Adrenalectomy #MedicalTherapy
**The Impact**
Primary aldosteronism is more than just high blood pressure. It heightens the risk of stroke and kidney disease by over double and places patients at thrice the risk for atrial fibrillation. By identifying and treating PA appropriately, we not only improve blood pressure management but also significantly reduce cardiovascular and renal complications. #HealthInnovation #Endocrinology
In summary, screening for PA can significantly transform hypertension management, offering a pathway to targeted therapies. For those navigating hypertension’s complexities, considering primary aldosteronism might just be the game changer we need. Remember, effective diagnosis and tailored treatment hold the key to better health outcomes. Stay informed, stay healthy. #Cardiology #HealthcareR
30 Mar 2025
My heart failure patient is hypotensive, Now What?
Is low blood pressure hindering your heart failure treatment? How do you balance life-saving medications with hypotension? We explore the definitions, causes, and practical solutions to optimize patient care. Learn how to navigate ARNI, beta-blockers, SGLT2 inhibitors, and MRAs effectively.
7 Mar 2025
Do Medications Leave a Legacy? What You Should Know
In this episode of Cardio Buzz, we explore the intriguing concept of the 'legacy effect' of medications like those used in treating diabetes, hypertension, hypercholesterolemia, and chronic kidney disease. We'll delve into landmark studies like the UKPDS, Steno-2, and more, examining the lasting impacts of medications such as Repatha, Candesartan, and Empagliflozin. Learn how these drugs contribute to disease regression, modify genes, and prevent non-fatal events to grant long-term protective effects.
00:00 Introduction: The Challenge of Lifelong Medication 00:57 Exploring the Legacy Effect of Medications
01:33 Diabetes Medications: Long-Term Benefits
03:15 Hypertension Medications: Persistent Effects
03:58 Cholesterol Medications: Lasting Impact
04:49 Kidney Disease Medications: Prolonged Benefits
06:12 Understanding the Legacy Effect Mechanism
09:13 Implications and Final Thoughts
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
220,180
Score snapshot 15 Sept 2025
Spotify
5.0 / 5
3 ratings
Podcast Authority Score: 42 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
36
Social presence
0
YouTube
86
Engagement
32
Contact Cardio Buzz
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Cardio Buzz?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
